TRENTON, N.J. -- Pfizer Inc., the world's biggest drugmaker, said today it will begin disclosing all sizable payments it makes to doctors, including those who test experimental drugs in people, a first for the industry.
The disclosures would begin early next year and are planned to include all payments to a doctor or other prescriber exceeding $500 in a year, the New York-based company told The Associated Press.
The move comes after introduction last month of legislation to require such disclosures, and revelations of astronomical payments to some doctors that were not revealed to universities and hospitals that employed them.
The disclosures would begin early next year and are planned to include all payments to a doctor or other prescriber exceeding $500 in a year, the New York-based company told The Associated Press.
The move comes after introduction last month of legislation to require such disclosures, and revelations of astronomical payments to some doctors that were not revealed to universities and hospitals that employed them.
Read the full article in the LA Times HERE.